Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02610361
Title Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors BeiGene
Indications

Advanced Solid Tumor

Therapies

BGB-283

Age Groups: adult
Covered Countries

Facility Status City State Zip Country Details
Chris O'Brien Lifehouse Camperdown New South Wales 2050 Australia Details
North Coast Cancer Institute Port Macquarie New South Wales 2444 Australia Details
Prince of Wales Hospital Randwick New South Wales 2031 Australia Details
Westmead Hospital Westmead New South Wales 2145 Australia Details
Tasman Oncology Research Ltd Southport Queensland 4215 Australia Details
Princess Alexandra Hospital Woolloongabba Queensland 4102 Australia Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
The Queen Elizabeth Hospital Woodville South South Australia 5011 Australia Details
Box Hill Hospital Box Hill Victoria 3128 Australia Details
Monash Medical Centre Clayton Victoria 3168 Australia Details
Austin Health Heidelberg Victoria Australia Details
Cabrini Hospital Malvern Victoria 3144 Australia Details
The Alfred Hospital Melbourne Victoria 3004 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria Australia Details
Royal Melbourne Hospital Parkville Victoria Australia Details
Linear Clinical Research Limited Nedlands Western Australia 6009 Australia Details
Christchurch Hospital Christchurch 8011 New Zealand Details
Dunedin Public Hospital Dunedin 9106 New Zealand Details
Waikato Hospital Hamilton New Zealand Details
Wellington Hospital Wellington New Zealand Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field